Key Highlights

● TRV shares ended 9 October 2026 at $368.62.

● Market data consensus target is $356.89 from 25 analysts.

● Targets range from $297.00 to $430.00.

● Roth Capital raised its target from $345 to $425.

Shares of Travelers (NYSE:TRV), a member of the S&P 500, closed at $368.62 on Friday 9 October 2026. The shares trade above the average analyst target.

What Is the Latest Analyst Price Target?

Market data reports a consensus price target of $356.89 from 25 analysts with ratings in the past 12 months, with a high of $430.00 and a low of $297.00. Against the $368.62 close, the consensus target suggests a figure about 3.2% below the current share price. The second data set shows a mean of $360.54 and a median of $359.50 across 29 analysts, with a high of $430 and a low of $262, implying about 2.2% below its quoted price of $368.75.

Recent named broker targets are also consistent with these averages: JPMorgan at $352, Mizuho at $345, Cantor Fitzgerald at $378, Piper Sandler at $340 and Wells Fargo at $334.

What Are Wall Street Analysts Saying?

Market data shows 8 Buy ratings (4 Strong Buy and 4 Buy), 12 Hold and 5 Sell, a Hold consensus. The second data set lists 5 Strong Buy, 1 Buy, 17 Hold, 2 Sell and 4 Strong Sell, also a Hold consensus.

Recent named actions include the following. On 9 October 2026, JPMorgan raised its target from $348 to $352 with a Neutral rating, and on 7 October Mizuho lowered its target from $348 to $345, also Neutral, while Cantor Fitzgerald raised its target from $377 to $378 with an Overweight rating. In July, after the company's quarterly report, Roth Capital raised its target from $345 to $425 with a Buy rating, and Truist raised its target from $395 to $425. Goldman Sachs downgraded the shares from Neutral to Sell with a $350 target and TD Cowen downgraded from Hold to Sell with a $297 target. Market data records five downgrades and four upgrades over the previous 90 days.

What Could Help the Stock Reach the Price Target?

Because the consensus target is below the share price, the question is better framed as what could lift targets and the share price together. Several brokers raised targets in July, and Roth Capital and Truist are at $425, well above the consensus. If more analysts move towards those levels, the average could rise. Strong profitability could support higher forecasts.

What Could Prevent the Stock Reaching the Target?

The shares already trade above the consensus, so analysts on average see limited near-term upside. Five Sell ratings on market data, and downgrades from Goldman Sachs and TD Cowen, show that some analysts regard the valuation as stretched. Morgan Stanley and Barclays both hold Underweight ratings with targets of $330 and $318.

The Analyst Case for Travelers, in Numbers

Travelers closed at $368.62 on 9 October 2026, against a market data consensus target of $356.89. In July, after the company's quarterly report, Roth Capital raised its target from $345 to $425 with a Buy rating, and Truist raised its target from $395 to $425.